Bristol-Myers Squibb logo

Bristol-Myers Squibb

BMY | NYSE
Chart Builder DCF Calculator
$62.48
+$1.09 (+1.78%)
At close: Oct 30, 2026, 4:00 PM ET
$62.32
-$0.16 (-0.26%)
Pre-market: Nov 2, 2026, 7:16 AM ET
Fiscal Quarter
Period Ending
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
Revenue
13.07B 12.97B 11.49B 12.5B 12.22B 12.27B 11.2B 12.34B 11.89B 12.2B 11.87B 11.48B 10.97B 11.23B 11.34B 11.41B 11.22B 11.89B 11.65B 11.99B 11.62B 11.7B 11.07B
Cost of Revenue
4.15B 3.73B 3.42B 4.1B 3.44B 3.37B 3.03B 4.81B 2.96B 3.27B 2.93B 2.75B 2.51B 2.88B 2.57B 2.59B 2.35B 2.72B 2.47B 2.36B 2.29B 2.45B 2.84B
Gross Profit
8.92B 9.25B 8.07B 8.41B 8.79B 8.9B 8.17B 7.53B 8.94B 8.93B 8.93B 8.73B 8.46B 8.35B 8.77B 8.81B 8.87B 9.17B 9.18B 9.63B 9.33B 9.25B 8.23B
Operating Income
2.84B 4.03B 3.37B 2.81B 3.64B 3.77B 3.5B 510M 2.17B 1.69B 1.51B 1.9B 1.96B 1.9B 2.43B 1.69B 2.1B 2.64B 2.67B 2.25B 2.02B 2.34B 1.83B
Interest Income
n/a 101M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
2.54B 4.09B 3.24B 1.47B 3.11B 1.77B 2.97B 175M 1.68B 1.29B -11.52B 1.67B 2.14B 1.86B 2.77B 1.86B 2.21B 1.96B 1.69B 1.86B 2.16B 1.55B 2.53B
Net Income
2.16B 3.32B 2.68B 1.09B 2.2B 1.31B 2.46B 72M 1.21B 1.68B -11.91B 1.76B 1.93B 2.07B 2.26B 2.02B 1.61B 1.42B 1.28B 2.37B 1.55B 1.06B 2.02B
Selling & General & Admin
1.7B 1.83B 1.62B 2.18B 1.79B 1.71B 1.58B 2.14B 1.98B 1.93B 2.37B 2.07B 2B 1.93B 1.76B 2.27B 1.93B 1.79B 1.83B 2.35B 1.79B 1.88B 1.67B
Research & Development
2.37B 2.96B 2.65B 2.59B 2.53B 2.58B 2.26B 3.19B 2.37B 2.9B 2.7B 2.48B 2.24B 2.26B 2.32B 2.51B 2.42B 2.32B 2.26B 2.61B 2.98B 2.48B 2.22B
Other Expenses
2.02B 437M 437M 826M 831M 830M 830M 1.69B 2.41B 2.42B 2.36B 2.28B 2.26B 2.26B 2.26B 2.34B 2.42B 2.42B 2.42B 2.42B 2.55B 2.55B 2.51B
Operating Expenses
6.08B 5.22B 4.7B 5.59B 5.15B 5.12B 4.67B 7.02B 6.76B 7.24B 7.42B 6.83B 6.5B 6.45B 6.34B 7.12B 6.77B 6.53B 6.51B 7.38B 7.31B 6.91B 6.4B
Interest Expense
403M 407M 411M 432M 480M 485M 494M 496M 505M 521M 425M 316M 280M 282M 288M 294M 299M 313M 326M 323M 328M 330M 353M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a 1.58B n/a 1.98B n/a 2.37B n/a 2B n/a 1.76B 2.27B 1.93B n/a 1.83B 2.35B 1.79B n/a 1.67B
Cost & Expenses
10.23B 8.95B 8.12B 9.69B 8.58B 8.5B 7.7B 11.83B 9.72B 10.51B 10.35B 9.57B 9.01B 9.33B 8.91B 9.71B 9.12B 9.25B 8.98B 9.73B 9.61B 9.36B 9.24B
Income Tax Expense
374M 770M 561M 384M 919M 460M 509M 99M 461M -398M 392M -88M 203M -218M 503M -166M 601M 529M 404M -514M 605M 492M 501M
Shares Outstanding (Basic)
2.04B 2.04B 2.04B 2.04B 2.04B 2.04B 2.03B 2.03B 2.03B 2.03B 2.02B 2.03B 2.06B 2.09B 2.1B 2.11B 2.13B 2.13B 2.15B 2.15B 2.22B 2.23B 2.24B
Shares Outstanding (Diluted)
2.05B 2.05B 2.04B 2.04B 2.04B 2.04B 2.04B 2.04B 2.03B 2.03B 2.02B 2.03B 2.06B 2.1B 2.11B 2.12B 2.15B 2.15B 2.16B 2.22B 2.24B 2.25B 2.27B
EPS (Basic)
1.06 1.62 1.31 0.53 1.08 0.64 1.21 0.04 0.60 0.83 -5.89 0.87 0.94 0.99 1.08 0.96 0.75 0.67 0.60 1.10 0.70 0.47 0.90
EPS (Diluted)
1.05 1.62 1.31 0.53 1.08 0.64 1.20 0.04 0.60 0.83 -5.89 0.87 0.93 0.99 1.07 0.95 0.75 0.66 0.59 1.07 0.69 0.47 0.89
EBITDA
2.94B 5.09B 4.25B 2.88B 4.61B 3.27B 4.48B 2.55B 4.77B 4.4B -8.56B 4.45B 4.85B 4.57B 5.49B 4.67B 5.1B 4.85B 4.6B 4.76B 5.21B 4.6B 5.55B
EBIT
2.94B 4.49B 3.65B 1.9B 3.59B 2.26B 3.47B 671M 2.18B 1.81B -11.09B 1.99B 2.42B 2.14B 3.06B 2.15B 2.51B 2.27B 2.01B 2.18B 2.49B 1.88B 2.88B
Depreciation & Amortization
n/a 594M 594M 977M 1.01B 1.01B 1.01B 1.88B 2.59B 2.6B 2.53B 2.46B 2.44B 2.43B 2.43B 2.52B 2.59B 2.58B 2.58B 2.58B 2.73B 2.71B 2.67B

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.